News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest L.A. McKeown December 11, 2023
News Daily News Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes Michael O'Riordan December 08, 2023
News Daily News No Safety Concerns Seen With Inclisiran in Large ORION Analysis Michael O'Riordan December 06, 2023
News Daily News Statin Use Has Plateaued in US Primary Prevention Patients Michael O'Riordan December 05, 2023
News Daily News Oral GLP-1 Drug Danuglipron to Move Forward, but With Tweaks to Dose L.A. McKeown December 01, 2023
News Daily News Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s Michael O'Riordan November 29, 2023
News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
News Conference News AHA 2023 Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation L.A. McKeown November 17, 2023
Presentation AHA 2023 Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events Presenter: Jing Li November 16, 2023
News Conference News AHA 2023 New CVD Risk Tool Can Spur Even Earlier Talk About Prevention Yael L. Maxwell November 14, 2023
News Conference News AHA 2023 ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients Todd Neale November 13, 2023
News Conference News AHA 2023 Slash Dietary Sodium, Slash Blood Pressure: CARDIA-SSBP Michael O'Riordan November 12, 2023
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023